![]() ![]() ![]() This includes appropriate screening and monitoring, utilization of hospital resources to maximize non-pharmacologic care, guidance on appropriate pharmacological intervention and weaning, and best discharge practices. This clinical practice guideline was developed with the goal of standardization of care for OENs, both those with and without NAS, based upon current evidence and best practices. However, despite maximizing non-pharmacological interventions some OENs with NAS will require pharmacological therapy. Non-pharmacological measures (soothing, swaddling, low stimulation environments, etc.) are the mainstay of therapy and are associated with shorter lengths of hospital stay, decreased severity of symptoms, and decreased pharmacological therapy utilization. Unfortunately, the incidence of OENs is increasing in the United States and, more specifically, in Tennessee. However, all Opioid Exposed Neonates (OENs) require specialized monitoring and care. While infants exposed to in utero opioids may have withdrawal symptoms, not all will progress to developing NAS. Neonatal Abstinence Syndrome (NAS) is a constellation of withdrawal symptoms in neonates exposed to opioids in utero. CLINICAL PRACTICE GUIDELINES (FULL LIST) NEONATAL ABSTINENCE SYNDROME (CPG) ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |